Clene Inc. (CLNNW)
Clene Announces Registered Direct Offering of Over $28 Million
Evolus Inc (EOLS)
Evolus - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue
Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones
Evolus Inc (EOLS)
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue
Clene Inc. (CLNN)
Clene Announces Registered Direct Offering of Over $28 Million
CorMedix Inc. (CRMD)
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Lexicon Pharmaceuticals Inc. (LXRX)
Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”
Royalty Pharma (RPRX)
Royalty Pharma Announces Dividend Increase
Exact Sciences Corporation (EXAS)
DEFM14A (Proxy Statement - Merger or Acquistion (definitive)) SEC Filing
Cellectar Biosciences Inc. (CLRB)
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference